VCYT - Veracyte, Inc.

Veracyte, Inc.

6000 Shoreline Court
Suite 300
South San Francisco, CA 94080
United States
650 243 6300
https://www.veracyte.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 787

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Marc A. Stapley	CEO & Director	1.25M	N/A	1970
Ms. Bonnie H. Anderson	Co-Founder & Director	N/A	N/A	1958
Ms. Rebecca Chambers	Exec. VP & CFO	772.41k	N/A	1978
Ms. Annie McGuire	Exec. VP, Gen. Counsel & Chief People Officer	633.65k	N/A	1981
Mr. Jonathan Wygant	VP & Chief Accounting Officer	N/A	N/A	1971
Mr. Steven French	Sr. VP & Chief Information Officer	N/A	N/A	N/A
Ms. Tracy Morris	VP of Global Corp. Communications	N/A	N/A	N/A
Mr. Robert Brainin	Exec. VP & Chief Bus. Officer	N/A	N/A	1971
Dr. Fabienne Hermitte Ph.D.	Sr. VP of Global Quality & Regulatory Affairs	N/A	N/A	N/A
Dr. John Leite Ph.D.	Sr. VP and GM of Pulmonology & Market Access	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Corporate governance

Veracyte, Inc.’s ISS governance QualityScore as of 1 June 2023 is 5. The pillar scores are Audit: 5; Board: 2; Shareholder rights: 5; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.